目的观察口腔干燥症患者的临床表现及唾液分泌情况，了解唾液分泌减少与临床表征之间的相关关系。
Objective to observe the general status, subjective syndromes, objective signs and salivary secretion of xerostomia patients for studying their correlations.
本发明还提供了胆碱酯酶抑制剂在制备用于治疗口腔干燥症的对口腔粘膜局部给药的药物方面的用途。
The invention also provides a use of cholinesterase inhibitor in the treatment of xerostomia for topical delivery to the oral mucosa.
4百万患有干燥综合症的美国人也更易于有口腔健康问题。
The 4 million Americans who have Sjögren's syndrome are more prone to have oral health problems, too.
应用推荐